These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 9821023)

  • 21. QT interval prolongation and torsade de pointes.
    Patanè S; Marte F; Di Bella G
    Int J Cardiol; 2009 Jan; 131(2):e51-3. PubMed ID: 17689729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prolongation of the QT interval and torsade de pointes caused by ketanserin].
    Arfiero S; Ometto R; Vincenzi M
    G Ital Cardiol; 1990 Sep; 20(9):869-72. PubMed ID: 2079190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug therapy for torsade de pointes.
    Banai S; Tzivoni D
    J Cardiovasc Electrophysiol; 1993 Apr; 4(2):206-10. PubMed ID: 8269292
    [TBL] [Abstract][Full Text] [Related]  

  • 24. QT interval prolongation, torsade de pointes and renal disease.
    Patanè S; Marte F; Di Bella G; Currò A; Coglitore S
    Int J Cardiol; 2008 Nov; 130(2):e71-3. PubMed ID: 18255176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intracoronary acetylcholine-induced prolongation of the QT interval and Torsade des Pointes in long QT interval syndrome.
    Aizawa Y; Matsubara T; Higuchi K; Washizuka T; Tamura Y; Uchiyama H; Igarashi Y; Shibata A
    Jpn Heart J; 1994 Sep; 35(5):683-8. PubMed ID: 7830332
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug-induced long QT syndrome and torsade de pointes.
    Morissette P; Hreiche R; Turgeon J
    Can J Cardiol; 2005 Aug; 21(10):857-64. PubMed ID: 16107909
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Torsade de pointes resulting from the addition of droperidol to an existing cytochrome P450 drug interaction.
    Michalets EL; Smith LK; Van Tassel ED
    Ann Pharmacother; 1998; 32(7-8):761-5. PubMed ID: 9681092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Torsade de pointes induced by intravenous and long-term oral amiodarone therapy in a patient with dilated cardiomyopathy.
    Yamada S; Kuga K; Yamaguchi I
    Jpn Circ J; 2001 Mar; 65(3):236-8. PubMed ID: 11266201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long QTc interval and torsade de pointes caused by fluconazole.
    Pham CP; de Feiter PW; van der Kuy PH; van Mook WN
    Ann Pharmacother; 2006; 40(7-8):1456-61. PubMed ID: 16849620
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Amiodarone therapy after sotalol-induced torsade de pointes: prolonged QT interval and QT dispersion in differentiation of pro-arrhythmic effects].
    van de Loo A; Klingenheben T; Hohnloser SH
    Z Kardiol; 1994 Dec; 83(12):887-90. PubMed ID: 7846927
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of atropine on QT prolongation and torsade de pointes induced by intracoronary acetylcholine in the long QT syndrome.
    Furushima H; Niwano S; Chinushi M; Yamaura M; Taneda K; Washizuka T; Aizawa Y
    Am J Cardiol; 1999 Mar; 83(5):714-8. PubMed ID: 10080424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Torsade de pointes associated with encephalitis.
    Alehan D; Ceviz N; Celiker A
    Turk J Pediatr; 1999; 41(3):395-8. PubMed ID: 10770105
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [QT interval prolongation and psychotropic drugs in children and adolescents: proposed guideline].
    van Aerde KJ; Kalverdijk LJ; Reimer AG; Widdershoven JA
    Ned Tijdschr Geneeskd; 2008 Aug; 152(32):1765-70. PubMed ID: 18754307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effective use of magnesium for acquired torsade de pointes in a 4-month-old infant.
    Bell D; Thoele DG; Mander G; Bauman JL
    Pediatr Cardiol; 1995; 16(2):79-81. PubMed ID: 7784240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Azithromycin as a cause of QT-interval prolongation and torsade de pointes in the absence of other known precipitating factors.
    Kezerashvili A; Khattak H; Barsky A; Nazari R; Fisher JD
    J Interv Card Electrophysiol; 2007 Apr; 18(3):243-6. PubMed ID: 17546486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perioperative torsade de pointes: a systematic review of published case reports.
    Johnston J; Pal S; Nagele P
    Anesth Analg; 2013 Sep; 117(3):559-564. PubMed ID: 23744954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A case of torsade de pointes occurring in a newborn with persistent 2:1 atrioventricular block.
    Perticone F; Canepa SA; Ceravolo R; Cloro C; Mattioli PL
    Cardiology; 1993; 83(1-2):134-40. PubMed ID: 8261481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Ventricular tachyarrhythmia induced by low doses of sotalol: torsade de pointes or polymorphous ventricular tachycardia?].
    Ophoff N; Toker Y
    Z Kardiol; 1988 Jun; 77(6):393-7. PubMed ID: 3213144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. OTc prolongation and torsade de pointes ventricular tachycardia in a small dose voriconazole therapy.
    Elbey MA; Cil H; Onturk E; Islamoglu Y
    Eur Rev Med Pharmacol Sci; 2012 Jan; 16(1):100-2. PubMed ID: 22338554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Why is QT interval interesting?].
    Elming H; Sonne J; Lublin HK
    Ugeskr Laeger; 2002 Feb; 164(6):750-4. PubMed ID: 11851179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.